Transforming growth factor-a and hepatocyte growth factor are important stimulators of hepatocyte proliferation. In this series of experiments we sought to measure the expression of transforming growth factor-a mRNA by hepatocytes in response to toxic liver injury produced by carbon tetrachloride or
Liver regeneration and hepatocarcinogenesis in transforming growth factor-α-targeted mice
✍ Scribed by William E. Russell; William K. Kaufmann; Silvio Sitaric; Noreen C. Luetteke; David C. Lee
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 748 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0899-1987
No coin nor oath required. For personal study only.
✦ Synopsis
Transforming growth factor-a (TGFa), a member of the epidermal growth factor receptor ligand family, has been implicated in the regeneration and transformation of liver. Our recent development of mice that are homozygous for a disrupted TGFagene allowed us to assess the requirement for this growth factor in these complex processes. We report here that although a 70% hepatectomy produced a significant increase in hepatic TGFa protein levels in wild-type mice, liver regeneration nevertheless proceeded normally in the absence of the growth factor. The hepatocyte labeling indices determined for homozygous targeted and wild-type mice at 36 and 48 h after hepatectomy were comparable, and the total liver DNA to body weight ratios 8 d after hepatectomy were essentially identical for the two genotypes. These results indicate that TGFa is not necessary for liver regeneration. To test its requirement in liver carcinogenesis, young mice were administered single doses of diethylnitrosamine (DEN) with or without subsequent chronic treatment with the promoting agent phenobarbital (PB). Both wildtype and homozygous mutant male mice treated with DEN or DEN plus PB developed multiple preneoplastic foci or tumors by 9 mo of age with relatively high incidence. However, while five of 88 tumors in wild-type mice attained a diameter greater than 5 mm and were classified as hepatocellular carcinomas, none of 132 tumors in livers of targeted mice reached this size. Furthermore, three of these large wild-type tumors expressed significantly elevated levels of TGFa protein compared with normal liver. These results indicate that TGFa is not required for early events in chemically induced hepatocarcinogenesis but suggest that it could be important in the progression from small preneoplastic foci to large tumors.
📜 SIMILAR VOLUMES
In order to characterize the role of transforming growth factor-a (TGFa) during hepatocarcinogenesis, liver tissue was examined at 10, 16, and 19 weeks following initial 10-week diethylnitrosamine (50 mg Idrinking water) exposure in female Wistar rats. Liver tissue protein extracts were electrophore
Transforming growth factor a (TGFa) is supposed to chain polypeptide of 50 amino acids that is expressed in act as a mitogen for hepatocytes in an autocrine manner cultured hepatocytes and secreted into culture medium in vitro and in vivo. Retarded liver regeneration is a after stimulation with mito
Transforming growth factor  (TGF-) is a potent inhibitor of hepatocyte proliferation in vitro and is suggested to be a key negative regulator of liver growth. To directly address the role of TGF- signaling in liver regeneration in vivo, the TGF- type II receptor gene (Tgfbr2) was selectively del
After a partial hepatectomy, TGF-a mRNA has been shown of chronic liver disease; CH, chronic hepatitis; LC, liver cirrhosis; LI, labeling index; RTto increase in hepatocytes at the time of DNA synthesis con-PCR, reverse-transcriptase polymerase chain reaction; cDNA, complementary DNA.